A Single-arm, Open-label, Multi-center Phase II Clinical Study to Evaluate the Safety and Efficacy of Toripalimab Injection (JS001) Combined With Bevacizumab as the First-line Therapy for Advanced Hepatocellular Carcinoma (HCC)
Clinical trial NCT04605796 · COMPLETED
Trial details
- NCT number
- NCT04605796
- Sponsor
- Shanghai Junshi Bioscience Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-04-10
- Primary completion
- 2022-10-27
- Enrollment
- 54
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.